Archives

Insilico Medicine nominates ISM1745 as preclinical candidate for MTAP-deleted cancers

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announced the nomination of ISM1745, a potentially best-in-class MTA cooperative…
Read More...

Estrogen’s role in female binge drinking revealed by preclinical study

if (g_displayableSlots.mobileTopLeaderboard) { pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); }); } Weill Cornell MedicineDec 30 2024 The hormone estrogen regulates binge…
Read More...